Mabe Bio is a greentech startup based in São Paulo that combines technology and nature to create new materials from plants, such as bioleather and bioplastic. The company's slogan "Transformamos plantas em materiais de alto valor agregado" reflects its mission to transform plants into high-value-added materials. Their flagship product, Angico bioleather, aims to reshape the landscape of leather production by adopting an ecosystemic approach and leveraging cutting-edge green technology. Mabe Bio, founded in 2022, operates in the Biotechnology industry and is headquartered in Brazil. Mabe Bio is currently in the Seed Round funding stage, offering opportunities for interested investors to participate in their innovative and sustainable production solutions. Their focus on providing alternatives for industries seeking to reduce their carbon footprint positions them as a promising investment opportunity in the growing field of green technology. With a vision to revolutionize traditional material production through environmentally friendly methods, Mabe Bio presents an exciting prospect for venture capital firms looking to support impactful and forward-thinking startups in the biotechnology sector.
There is no investment information
No recent news or press coverage available for Mabe Bio.